@Ɛ: ߓ@T i2008-2017j


1.Ishii W, Ito S, Kondo Y, Tsuboi H, Mamura M, Goto D, Matsumoto I, Tsutsumi A, Okoshi Y, Hasegawa Y, Kojima H, Sakashita S, Aita K, Noguchi M, Sumida T.:
Intravascular large B-cell lymphoma with acute abdomen as a presenting symptom in a patient with systemic lupus erythematosus
J. Clin. Oncol. 26(9):1553-1555,2008

2.Horikoshi M, Ito S, Ishikawa M, Umeda N, Kondo Y, Tsuboi H, Hayashi T, Goto D, Matsumoto I, Sumida T.:
Efficacy of mizoribine pulse therapy in patients with rheumatoid arthritis who show reduced or insufficient response to infliximab.
Mod Rheumatol 19:229-234,2009

3.
Kondo Y, Ito S,Ohi Y, Satou H, Hiraoka T, Tsuboi H, Sugihara M, Hayashi T, Goto D, Matsumoto I, Sumida T.:
Atypical Cogan's Syndrome with Aortitis.
Intern. Med 48:1093-1097,2009


4.
Ito I, Kawasaki A, Ito S, Kondo Y, Sugihara M, Horikoshi M, Hayashi T, Goto D, Matsumoto I, Tsutsumi A, Takasaki Y, Hashimoto H, Matsuta K, Sumida T, Tsuchiya N.:
Replication of association between FAM167A(C8orf13)-BLK region and rheumatoid arthritis in a Japanese population.
Ann. Rheum. Dis.69:936-937,2010

5.Iwanami K, Matsumoto I, Yoshiga Y, Inoue A, Kondo Y, Yamamoto K, Tanaka Y, Minami R, Hayashi T, Goto D, Ito S, Nishimura Y, Sumida T.:
Altered peptide ligands inhibit arthritis induced by glucose-6-phosphate isomerase peptide.
Arthritis Res Ther.11:R167,Epub2009 Nov 9

6.Horikoshi M, Suzuki T, Sugihara M, Kondo Y, Tsuboi H, Uehara T, Hama M, Takase K, Ohno S, Ishigatsubo Y, Yoshida Y, Sagawa A, Ikeda K, Ota T, Matsumoto I, Ito S, Sumida T.:
Comparison of low-field dedicated extremity magnetic resonance imaging with articular ultrasonography in patients with rheumatoid arthritis.
Modern Rheumatology 20:556-560,2010

7.Kawasaki A, Furukawa H, Kondo Y, Ito S, Hayashi T, Kusaoi M, Matsumoto I, Tohma S, Takasaki Y, Hashimoto H, Sumida T, Tsuchiya N.:
Toll-like receptor 7(TLR7) SNPs in the 3' untranslated region and intron additively contribute to susceptibility to systemic lupus erythematosus in a Japanese female population.
Arthritis Res. Ther. 13(2):R41,2011

8.Kondo Y, Iizuka M, Wakamatsu E, Yao Z, Tahara M, Tsuboi H, Sugihara M, Hayashi T, Yoh K, Takahashi S, Matsumoto I, Sumida T.:
Overexpression of T-bet gene regulates murine autoimmune arthritis
Arthritis Rheum.64(1):162-172,2012

9.Kawasaki A, Furukawa H, Kondo Y, Ito S, Hayashi T, Kusaoi M, Matsumoto I, Tohma S, Takasaki Y, Hashimoto H, Sumida T, Tsuchiya N.:
Association of PHRF1-IRF7 region polymorphism with clinical manifestations of systemic lupus erythematosus in a Japanese population.
Lupus 21(8):890-5.2012

10.Tsuboi H, Matsuo N, Iizuka M, Tsuzuki S, Kondo Y, Tanaka A, Moriyama M, Matsumoto I, Nakamura S, Sumida T.:
Analysis of IgG4 class switch-related molecules in IgG4-related disease.
Arthritis Res. Ther. 14(4):R171,2012

11.Suzuki T, Horikoshi M, Sugihara M, Hirota T, Ogishima H, Umeda N, Kondo Y, Tsuboi H, Hayashi T, Chino Y, Matsumoto I, Sumida T.:
Therapeutic efficacy of tocilizumab in patients with rheumatoid arthritis refractory to anti-tumor necrosis factor inhibitors: One year follow-up by low-field extremity MRI.
Mod. Rheumatol 23(4):782-7,2013

12.Iizuka M, Tsuboi H, Matsuo N, Kondo Y, Asashima H, Matsui M, Matsumoto I, Sumida T.:
The crucial roles of IFN-g in the development of M3 muscarinic acetylcholine receptor induced Sjogren's syndrome-like sialadenitis.
Mod. Rheumatol 23(3):614-6, 2013

13.Ito S, Ogishima H, Kondo Y, Sugihara M, Hayashi T, Chino Y, Goto D, Matsumoto I, Sumida T.:
Early diagnosis and treatment of steroid-induced diabetes mellitus in patients with rheumatoid arthritis and other connective tissue diseases.
Mod Rheumatol 21(1):52-59,2014

14.Furukawa H, Kawasaki A, Oka S, Shimada K, Masui T, Ikenaka T, Hashimoto A, Okazaki Y, Takaoka H, Futami H, Komiya A, Kondo Y, Ito S, Hayashi T, Matsumoto I, Kusaoi M, Takasaki Y, Nagai T, Hirohata S, Setoguchi K, Suda A, Nagaoka S, Kono H, Okamoto A, Chiba N, Suematsu E, Fukui N, Hashomoto H, Sumida T, Ono M, Tsuchiya N, Tohma S:
Association of a Single Nucleotide Polymorphism in the SH2D1A Intronic Region with Systemic Lupus Erythematosus.
Lupus 22(5):497-503,2013

15.Ogishima H, Tsuboi H, Umeda N, Horikoshi M, Kondo Y, Sugihara M, Suzuki T, Matsumoto I, Sumida T:
Analysis of subclinical synovitis detected by ultrasonography and low-field magnetic resonance imaging in patients with rheumatoid arthritis.
Mod Rheumatol 24(1)60-68,2014

16..Hagiya C, Tsuboi H, Yokosawa M, Hagiwara S, Takai C, Hirota T, Asashima H, Miki H, Umeda N, Horikoshi M, Kondo Y, Sugihara M, Ogishima H, Suzuki T, Hiraoka T, Kaji Y, Matsumoto I, Ohshika T, Sumida T.:
Clinicopathological features of IgG4-related disease complicated with orbital involvement.
Mod Rheumatol 24(3):471-6,2014

17.Furukawa H, Kawasaki A, Oka S, Ito I, Shimada K, Sugii S, Hashimoto A, Komiya A, Fukui N, Kondo Y, Ito S, Hayashi T, Matsumoto I, Kusaoi M, Amano H, Nagai T, Hirohara S, Setoguchi K, Kono Hm Okamoto A, Chiba N, Suematsu E, Katayama M, Migita K, Suda A, Ohno S, Hashimoto H, Takasaki Y, Sumida T, Nagaoka S, Tsuchiya N, Tohma S.:
Human Leukocyte Antigens and Systemic Lupus Erythematosus: A Protective Role for the HLA-DR6 alleles DRB1*13:02 and *14:03.

PLoS One 9(2):e87792,2014

18.Iizuka M, Tsuboi H, Asashima H, Hirota T, Kondo Y, Matsui M, Matsumoto I, Sumida T.:
M3 muscarinic acetylcholine receptor reactive IL-17- producing T cells promotes development of Sjogren's syndrome like sialadenitis.
Mod Rheumatol (in press)

19.Hagiwara S, Tsuboi H, Hagiya C, Yokosawa M, Hirota T, Ebe H, Takahashi H, Ogishima H, Asashima H, Kondo Y, Umeda N, Suzuki T, Hitomi S, Matsumoto I, Sumida T.:
Pulmonary nocardiosis in patients with connective tissue disease: A report of two cases.
Intractable Rare Dis Res 3(1):25-28,2014

20.Segawa S, Goto D, Horikoshi M, Kondo Y, Umeda N, Hagiwara S, Yokosawa M, Hirota T, Miki H, Tsuboi H, Ogishima H, Suzuki T, Matsumoto I, Sumida T.F
Involvement of CD161+V1+T cells in systemic sclerosis: Association with interstitial pneumonia.
Rheumatology(Oxford) 53(12):2259-69,2014

21.Ebe H, Tsuboi H, Hagiya C, Takahashi H, Yokosawa M, Hagiwara S, Hirota T, Kurashima Y, Takai C, Miki H, Asashima H, Umeda N, Kondo Y, Ogishima H, Suzuki T, Chino Y, Matsumoto I, Sumida T.:
Clinical features of patients with IgG4-related disease complicated with perivascular lesions.
Mod Rheumatol 25(1):105-9,2015

22.Tsuboi H, Ohira H, Asashima H, Tsuzuki S, Iizuka M, Matsuo N, Kondo Y, Matsumoto I, Sumida T.:
Anti-M3 muscarinic acetylcholine receptor antibodies in patients with primary biliary cirrhosis.
Hepatol Res(in press)

23.Iizuka M, Wakasa Y, Tsuboi H, Asashima H, Hirota T, Kondo Y, Matsumoto I, Sumida T, Takaiwa F.:
Prophylactic effect of the oral administration of transgenic rice seeds containing altered peptide ligands of type II collagen on rheumatoid arthritis.
Biosci Biotech Bioch 78(10):1662-8,2014

24.Tsuboi H, Nakai Y, Iizuka M, Asashima H, Hagiya C, Tsuzuki S, Hirota T, Miki H, Hagiwara S, Kondo Y, Tanaka A, Moriyama M, Matsumoto I, Nakamura S, Yoshihara T, Abe K, Sumida T.:
DNA microarray analysis of labial salivary glands in IgG4-related disease. Comparison with Sjogren's syndrome.
Arthritis Rheum 66(10):2892-9,2014

25.Iizuka M, Wakasa Y, Tsuboi H, Asashima H, Hirota T, Kondo Y, Matsumoto I, Takaiwa F, Sumida T.:
Suppression of collagen-induced arthritis by oral administration of transgenic rice seeds expressing altered peptide ligands of type II collagen.
Plant Biotechnol J12:(8):1143-53,2014

26.Suzuki T, Hirota T, Ogishima H, Umeda N, Kondo Y, Yokosawa M, Miki H, Hagiwara S, Tsuboi H, Matsumoto I, Sumida T.:
Subclinical inflammation with tocilizumab treatment of rheumatoid arthritis: MRI evaluation for two years.
Int J Rheum Dis 18(1):108-10,2015

27.Tsuboi H, Matsumoto I, Hagiwara S, Hirota T, Takahashi H, Ebe H, Yokosawa M, Hagiya C, Asashima H, Takai C, Miki H, Umeda N, Kondo Y, Ogishima H, Suzuki T, Hirata S, Saito K, Tanaka Y, Horai Y, Nakamura H, Kawakami A, Sumida T.:
Efficacy and safety of abatacept for patients with Sjogren's syndrome associated with rheumatoid arthritis. ROSE (Rheumatoid Arthritis with Orencia Trial toward Sjogren's syndrome Endocrinopathy) trial. An open label, one-year, prospective study. Interim analysis of 32 patients for 24 weeks.
Mod Rheumatol 25(2):187-93,2015

28.Yokosawa M, Tsuboi H, Nasu K, Hagiya C, Hagiwara S, Hirota T, Ebe H, Takahashi H, Asashima H, Kondo Y, Ogishima H, Suzuki T, Minami M, Bukawa H, Matsumoto I, Sumida T.:
Usefulness of MR imaging of the parotid glands in patients with secondary Sjogrenfs syndrome associated with rheumatoid arthritis.
Mod Rheumatol 25(3):415-20,2015

29.Tahara M, Kondo Y, Yokosawa M, Tsuboi H, Satoru T, Sibayama S, Matsumoto I, Sumida T. :
T-bet regulates differentiation of forkhead box protein 3+ regulatory T cells in programmed cell death-1-deficient mice..
Clin Exp Immunol 179(2):197-209,2015

30.Kawasaki A, Furukawa H, Nishida N, Warabi E, Kondo Y, Ito S, Matsumoto I, Kusaoi M, Amano H, Suda A, Nagaoka S, Setoguchi K, Nagai T, Hirohata S, Shimada K, Sugai S, Okamoto A, Chiba N, Suematsu E, Ohno S, Katayama M, Okamoto A, Kono H, Tokunaga K, Takasaki Y, Hashimoto H, Sumida T, Tohma S, Tsuchiya N.:
Association of Functional Polymorphisms in Interferon Regulatory Factor 2 (IRF2) with Susceptibility to Systemic Lupus Erythematosus: a Case-Control Association Study.
PLoS One 9(10):e109764,2014

31.Takahashi H, Tsuboi H, Kurata I, Takahashi H, Inoue S, Ebe H, Yokosawa M, Hagiwara S, Hirota T, Asashima H, Kaneko S, Kawaguchi H, Kurashima Y, Miki H, Umeda N, Kondo Y, Ogishima H, Suzuki T, Matsumoto I, Sumida T.:
Predictors of the response to treatment in acute lupus 1 hemophagocytic syndrome.
Lupus 24(7):659-68,2015

32.Iizuka M, Tsuboi H, Matsuo N, Asashima H, Hirota T, Kondo Y, Iwakura Y, Takahashi S, Matsumoto I, Sumida T.:
A crucial role of RORgt in the development of spontaneous sialadenitis-like Sjogren's syndrome.
J Immunol 194(1):56-67,2015

33.Kurata I, Tsuboi H, Takahashi H, Inoue S, Ebe H, Hagiwara S, Umeda N, Kondo Y, Ogishima H, Suzuki T, Matsumoto I, Hoshi S, Oshika T, Sumida T.:
Successful treatment with infliximab for refractory uveitis in a patient with Behcet's disease on hemodialysis and a review of literature for infliximab use on hemodialysis.
Intern Med 54(12):1553-7,2015

34.Takahashi H, Tsuboi H, Ogishima H, Yokosawa M, Takahashi H, Yagishita M, Abe S, Hagiwara S, Asashima H, Umeda N, Kondo Y, Suzuki T, Matsumoto I, Sumida T.:
FDG-PET/CT can reveal subclinical prostatitis in a patient with IgG4-related disease.
Rheumatology (Oxford) 54(6):1113,2015

35.Kurata I, Tsuboi H, Takahashi H, Yagishita M, Abe S, Ebe H, Takahashi H, Asashima H, Hirota T, Hagiwara S, Umeda N, Kondo Y, Ogishima H, Suzuki T, Matsumoto I, Sumida T.:
A case of relapsing neurosarcoidosis with brain nodules and hydrocephalus successfully treated by corticosteroid and methotrexate.
Rheumatology (Oxford) 54(7):1160,2015

36.Kondo Y, Yao Z, Tahara M, Izuka M, Yokosawa M, Kaneko S, Tsuboi H, Yoh K, Takahashi S, Matsumo I, Sumida T.:
Involvement of RORt-overexpressing T cells in the development of autoimmune arthritis in mice.
Arthritis Res Ther 17(1):105,2015

37.Asashima H, Tsuboi H, Iizuka M, Hirota T, Kondo Y, Matsumoto I, Sumida T.:
The Anergy Induction of M3 Muscarinic Acetylcholine Receptor-Reactive CD4+ T Cells Suppresses Experimental Sialadenitis-like Sjogren's Syndrome.
Arthritis Rheum 67(8):2213-25,2015

38.Hirota T, Suzuki T, Ogishima H, Hagiwara S, Ebe H, Takahashi H, Yokosawa M, Umeda N, Kondo Y, Tsuboi H, Matsumoto I, Sumida T.:
Evaluation of changes in magnetic resonance images following 24 and 52 weeks treatment of rheumatoid arthritis with infliximab, tocilizumab or abatacept.
Mod Rheumatol 26(1):29-35,2016

39.Takahashi H, Tsuboi H, Abe S, Yokosawa M, Hagiwara S, Asashima H, Hirota T, Umeda N, Kondo Y, Matsumoto I, Sumida T.:
Magnetic resonance imaging can reveal fascial vasculitis in a patient with microscopic polyangiitis.
Scand J Rheumatol 44(6):511-3,2015

40.Umeda N, Matsumoto I, Kawaguchi H, Kurashima Y, Kondo Y, Tsuboi H, Ogishima H, Suzuki T, Kagami Y, Sakyu T, Ishigami A, Maruyama N, Sumida T.:
Prevalence of soluble peptidylarginine deiminase 4 (PAD4) and anti-PAD4 antibodies in autoimmune diseases.
Clin Rheumatol 35(5):1181-8,2016

41.Miki H, Tsuboi H, Kaneko S, Takahashi H, Yokosawa M, Asashima H, Hirota T, Hagiwara S, Umeda N, Kondo Y, Nishimura B, Sugano M, Matsumoto I, Sumida T.:
A case of refractory Kimura disease with a buccal bulky mass successfully treated with
low-dose cyclosporine A: report and review of the literature.
Allergol Int 65(2):212-4,2016

42.Hagiwara S, Tsuboi H, Honda F, Takahashi H, Kurata I, Ohyama A, Yagishita M, Abe S, Kurashima Y, Kaneko S, Kawaguchi H, Takahashi H, Ebe H, Yokosawa M, Asashima H, Hirota T, Umeda N, Kondo Y, Matsumoto I, Sumida T.:
Association of anti-Ro/SSA antibody with response to biologics in patients with
rheumatoid arthritis.
Mod Rheumatol 26(6):857-862,2016

43.Tsuboi H, Matsumoto I, Hagiwara S, Hirota T, Takahashi H, Ebe H, Yokosawa M, Yagishita M, Takahashi H, Kurata I, Ohyama A, Honda F, Asashima H, Miki H, Umeda N, Kondo Y, Hirata S, Saito K, Tanaka Y, Horai Y, Nakamura H, Kawakami A, Sumida T.:
Effectiveness of abatacept for patients with Sjoren's syndrome associated with rheumatoid arthritis. An open label, multicenter, one-year, prospective study: ROSE (Rheumatoid Arthritis with Orencia Trial toward Sjoren's syndrome Endocrinopathy) trial.
Mod Rheumatol 26(6):891-899,2016

44.Segawa S, Goto D, Iizuka A, Kaneko S, Yokosawa M, Kondo Y, Matsumoto I, Sumida T.:
The regulatory role of IFN-g producing gammadelta T cells via the suppression of Th17 cell activity in bleomycin-induced pulmonary fibrosis.
Clin Exp Immunol 185(3):348-60,2016

45.Furukawa H, Oka S, Kawasak A, Shimada K, Sugii S, Matsushita T, Hashimoto A, Komiya A, Fukui N, Kobayashi K, Osada A, Ihata A, Kondo Y, Nagai T, Setoguchi K, Okamoto A, Okamoto A, Chiba N, Suematsu E, Kono H, Katayama M, Hirohata S, Sumida T, Migita K, Hasegawa M, Fujimoto M, Sato S, Nagaoka S, Takehara K, Tohma S, Tsuchiya N. :
Human leukocyte antigen and systemic sclerosis in Japanese: The sign of the four independent protective alleles, DRB1*13:02, DRB1*14:06,@DQB1*03:01, and DPB1*02:01.
PLoS One 11(4):e0154255,2016

46.Hachiya Y, Kawasaki A, Oka S, Kondo Y, Ito S, Matsumoto I, Kusaoi M, Amano H, Suda A, Setoguchi K, Nagai T, Shimada K, Sugii S, Okamoto A, Chiba N, Suematsu E, Ohno S, Katayama M, Kono H, Hirohata S, Takasaki Y, Hashimoto H, Sumida T, Nagaoka S, Tohma S, Furukawa H, Tsuchiya N.:
Association of HLA-G 3' Untranslated Region Polymorphisms with Systemic Lupus Erythematosus in a Japanese Population: a Case-control Association Study.
PLoS One 11(6):e0158065,2016

47.Hirota T, Tsuboi H, Iizuka-Koga M, Takahashi H, Asashima H, Yokosawa M, Kondo Y, Ohta M, Wakasa Y, Matsumoto I, Takaiwa F, Sumida T.:
Suppression of glucose-6-phosphate-isomerase induced arthritis by oral administration of transgenic rice seeds expressing altered peptide ligands of
glucose-6-phosphate-isomerase.
Mod Rheumatol 27(3):457-465,2017

48.Tahara M, Tsuboi H, Segawa S, Asashima H, Iizuka M, Hirota T, Takahashi H, Kondo Y, Matsui M, Matsumoto I, Sumida T.:
RORt antagonist suppresses M3 muscarinic acetylcholine receptor-induced Sjogren's syndrome-like sialadenitis.
Clin Exp Immunol 187(2):213-224,2017

49.Yokosawa M, Kondo Y, Tahara M, Iizuka M, Segawa S, Kaneko S, Tsuboi H, Yoh K, Takahashi S, Matsumoto I, Sumida T.:T-bet overexpression regulates AHR-mediated Th-17 differentiation through an IFN-independent pathway.
Clin Exp Immunol 188(1):22-35,2017

50.Abe S, Tsuboi H, Toko H, Honda F, Ohyama A, Takahashi H, Yokosawa M, Asashima H, Hagiwara S, Hirota T, Kondo Y, Matsumoto I, Sakai S, Aonuma K, Sumida T.:
The effectiveness of upfront pulmonary vasodilators combination therapy in addition to corticosteroids for pulmonary arterial hypertension associated with systemic lupus erythematosus: two successful cases utilizing both corticosteroids and an upfront combination of vasodilators.
Modern Rheumatol Case Reports(in press)

51.Honda F, Tsuboi H, Toko H, Ohyama A, Takahashi H, Abe S, Yokosawa M, Asashima H, Hagiwara S, Hirota T, Kondo Y, Matsumoto I, Sumida T.:
A case of recurrent Kikuchi-Fujimoto disease successfully treated by concomitant use of hydroxychloroquine and corticosteroid.
Intern Med (in press)

52.Takahashi H, Tsuboi H, Asashima H, Hirota T, Kondo Y, Moriyama M, Matsumoto I, Nakamura S, Sumida T.:
cDNA microarray analysis identifies NR4A2 as a novel molecule involved in the pathogenesis of Sjogren's syndrome.
Clin Exp Immunol (in press)

53.Takahashi H, Tsuboi H, Yokosawa M, Asashima H, Hirota T, Kondo Y, Matsumoto I, Sumida T.:
Diffusion-weighted magnetic resonance imaging of parotid glands before and after abatacept therapy in patients with Sjogren's syndrome associated with rheumatoid arthritis: Utility to evaluate and predict response to treatment.
Mod Rheumatol (in press)

54.Kawaguchi H, Tsuboi H, Yagishita M, Terasaki T, Terasaki M, Shimizu M, Honda F, Ohyama A, Takahashi H, Miki H, Yokosawa M, Asashima H, Hagiwara S, Kondo Y, Matsumoto I, Sumida T.:
A case of severe adult-onset Still disease with constrictive pericarditis and pleuritis successfully treated with tocilizumab in addition to corticosteroid and cyclosporin A.
Intern Med (in press)

55.Kawasaki A, Yamashita K, Hirano F, Sada KE, Tsukui D, Kondo Y, Kimura Y, Asako K, Kobayashi S, Yamada H, FurukawaH, Nagasaka K, Sugihara T, Yamagata K, Sumida T, Tohma S, Kono H, Ozaki S, Matsuo S, Hashimoto H, Makino H, Arimura Y, Harigai M, Tsuchiya N.
Association of ETS1 polymorphism with granulomatosis with polyangiitis and proteinase 3-anti-neutrophil cytoplasmic antibody positive vasculitis in a Japanese population.
J Hum Genet (in press)

56.Oku K, Atsumi T, Akiyama Y, Amano H, Azuma N, Bohgaki T, Horita T, Hosoya T, Ichinose K, Kato M, Katsumata Y, Kawaguchi Y, Kawakami A, Koga T, Kohsaka H, Kondo Y, Kubo K, Kuwana M, Mimori A, Mirori T, Mimura T, Murakami K, Nakano K, Nakayamada S, Ogishima H, Ohmura K, Saito K, Sano H, Shibuya M, Takahashi Y, Takasaki Y, Takeuchi T, Tamura N, Tanaka Y, Tsuboi H, Tsunoda S, Yukawa N, Yamakawa N, Yamamoto K, Sumida T.
Evaluation of the alternative classification criteria of systemic lupus erythematosus established by Systemic Lupus International Collaborating Clinics (SLICC).
Mod Rheumatol (in press)